Adaptive Biotechnologies
Barbara Sandoval Duke serves as a Research Scientist at Adaptive Biotechnologies Corp. since September 2021, where responsibilities include optimizing experimental design for ADCC and ADCP assays and assessing novel antibody performance through various assays. Previously, Barbara discovered T-cell receptors from donor repertoires and verified their activity through immunology assays at the same company. Prior experience includes a role as Research Associate II at San Jose State University from September 2018 to December 2020, where Barbara also worked as a Teaching Associate. Educational qualifications include a Master's degree in Biology from San Jose State University, obtained in May 2022, and a Bachelor of Science in Molecular Biology from the same institution, completed in 2018.
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.